Xact Kapitalforvaltning’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $3.02M | Sell |
35,716
-3,325
| -9% | -$281K | 0.06% | 251 |
|
|
2019
Q4 | $3.3M | Buy |
39,041
+1,378
| +4% | +$117K | 0.06% | 309 |
|
|
2019
Q3 | $2.54M | Buy |
37,663
+5,200
| +16% | +$350K | 0.05% | 348 |
|
|
2019
Q2 | $2.78M | Hold |
32,463
| – | – | 0.06% | 312 |
|
|
2019
Q1 | $2.88M | Sell |
32,463
-1,292
| -4% | -$115K | 0.07% | 285 |
|
|
2018
Q4 | $2.87M | Buy |
33,755
+7,900
| +31% | +$673K | 0.07% | 250 |
|
|
2018
Q3 | $2.51M | Buy |
25,855
+932
| +4% | +$90.4K | 0.05% | 338 |
|
|
2018
Q2 | $2.35M | Hold |
24,923
| – | – | 0.05% | 372 |
|
|
2018
Q1 | $2.02M | Buy |
24,923
+1,737
| +7% | +$141K | 0.05% | 401 |
|
|
2017
Q4 | $2.07M | Buy |
23,186
+2,212
| +11% | +$197K | 0.05% | 388 |
|
|
2017
Q3 | $1.95M | Buy |
20,974
+348
| +2% | +$32.4K | 0.06% | 372 |
|
|
2017
Q2 | $1.87M | Sell |
20,626
-331
| -2% | -$30.1K | 0.06% | 378 |
|
|
2017
Q1 | $1.84M | Buy |
20,957
+1,746
| +9% | +$153K | 0.06% | 382 |
|
|
2016
Q4 | $1.59M | Sell |
19,211
-689
| -3% | -$57.1K | 0.06% | 388 |
|
|
2016
Q3 | $1.84M | Buy |
+19,900
| New | +$1.84M | 0.07% | 335 |
|